Our goal is set the standard for blood function diagnostics in Sickle Cell Disease and a wide range of bleeding and clotting disorders.
Founder & Chief Executive Officer
Assistant Professor of Pediatric Critical Care Medicine and Associate in the Department of Physiology, Wayne State University School of Medicine., Children’s Hospital of Michigan. Previous business and technology consultant for Quantum Genomics, University of North Carolina at Chapel Hill – based startup specializing in models of human diseases. Past chairman of the board of directors for the SNMA.
Co-inventor of microfluidic flow-based clinical assays as a post-doctoral fellow in the Hines lab at Wayne State University School of Medicine. With Over 10 years of both basic science and clinical laboratory experience, Dr. White Co-directs bioassay innovation.
Co-inventor of microfluidic flow-based clinical assays in Hines lab at Wayne State University School of Medicine. With over 23 years of senior level research experience in toxicology, pharmacology, and blood-based assay development, Dr. Gao Co-directs bioassay innovation.
Chief Operating Officer
An experienced startup executive. Previously served as Mentor in Residence, Wayne State University Office of Technology Transfer, Managing Member Innoventures, CEO Meadowlark Energy, CEO Rapid Biosense.
Previously Senior Scientist, nanoRETE, Inc. Developed, validated, and optimized nanoRETE’s proprietary nanoparticle electrochemical-based biosensors for food pathogen and tuberculosis (TB) biomarker detection. Directs innovation efforts in bioassay analysis.